Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour, Residual”

783 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 783 results

Early research (Phase 1)Ended earlyNCT04748848
What this trial is testing

A Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidine in R/R Acute Myeloid Leukemia and Treatment-naïve Participants Not Eligible for Intensive Therapy

Who this might be right for
Leukemia, Myeloid
Celgene 1
Not applicableLooking for participantsNCT05965024
What this trial is testing

Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 377
Testing effectiveness (Phase 2)Study completedNCT01575860
What this trial is testing

Maintenance Lenalidomide in Lymphoma

Who this might be right for
Lymphoma
Abramson Cancer Center at Penn Medicine 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT03516279
What this trial is testing

Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease

Who this might be right for
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveMinimal Residual Disease
ECOG-ACRIN Cancer Research Group 40
Not applicableLooking for participantsNCT06216002
What this trial is testing

Incidence of Residual Neuromuscular Blockade in Fraility in OncoGynae Surgery

Who this might be right for
FrailtyNeuromuscular BlockadeGeneral Anesthetic Drug Adverse Reaction+2 more
Mahidol University 622
Testing effectiveness (Phase 2)Study completedNCT02988466
What this trial is testing

Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT

Who this might be right for
Hematologic Malignancies
Masonic Cancer Center, University of Minnesota 78
Not applicableActive Not RecruitingNCT05934929
What this trial is testing

Contribution of Residual Tumour DNA Testing on the Surgical Bed

Who this might be right for
Squamous Cell Carcinoma of the Oral Cavity
Centre Henri Becquerel 31
Not applicableLooking for participantsNCT07450612
What this trial is testing

Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection

Who this might be right for
Colorectal CancerAdenoma ColonAdenoma Colon Polyp+16 more
San Raffaele University 1,200
Testing effectiveness (Phase 2)Ended earlyNCT03686345
What this trial is testing

Midostaurin Associated With Standard Chemotherapy in Patients With Core-binding Factor Leukemia

Who this might be right for
Core Binding Factor Acute Myeloid Leukemia (CBF-AML)
Niguarda Hospital 34
Testing effectiveness (Phase 2)WithdrawnNCT03760445
What this trial is testing

HDM201 Added to CT in R/R or Newly Diagnosed AML

Who this might be right for
Leukemia, Myeloid, Acute
Novartis Pharmaceuticals
Not applicableActive Not RecruitingNCT06744075
What this trial is testing

Study of the Clearance of Minimal Residual Disease Measured at the End of First-line Treatment in Patients With Lymphoma

Who this might be right for
B-cell LymphomaHodgkin Lymphoma
Centre Henri Becquerel 108
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07247201
What this trial is testing

Integrating Allogeneic NK Cells in High-risk Advanced Stage III-IV Nasopharyngeal Cancer Patients

Who this might be right for
Nasopharyngeal Carcinoma (NPC)Minimal Residual DiseaseRecurrent Nasopharyngeal Carcinoma+1 more
Singapore General Hospital 31
Post-approval studies (Phase 4)Enrolling By InvitationNCT06437288
What this trial is testing

Hematoporphyrin Photodynamic Therapy for Esophageal Cancer

Who this might be right for
Esophageal CancerPhotodynamic Therapy
Sun Yat-sen University 198
Testing effectiveness (Phase 2)Ended earlyNCT04440982
What this trial is testing

Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients

Who this might be right for
Breast CancerNeoadjuvant Therapy
Lumicell, Inc. 98
Testing effectiveness (Phase 2)Ended earlyNCT02892201
What this trial is testing

Pembrolizumab in HNSCC With Residual Disease After Radiation

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Yale University 9
Testing effectiveness (Phase 2)WithdrawnNCT00676871
What this trial is testing

Evaluate the Safety, Tolerability, and Antitumor Activity of Continuous Intravenous Infusion of MEDI-538 in Adults With B-Cell Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
MedImmune LLC 30
Not applicableStudy completedNCT00005619
What this trial is testing

Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell Leukemia

Who this might be right for
Leukemia
Northwestern University 16
Testing effectiveness (Phase 2)Looking for participantsNCT05904106
What this trial is testing

Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML

Who this might be right for
Acute Myeloid Leukemia
Technische Universität Dresden 146
Testing effectiveness (Phase 2)Study completedNCT01215344
What this trial is testing

First Autologous Transplant on Minimal Residual Disease Markers in Previously Untreated Myeloma Undergoing Initial Treatment With Velcade

Who this might be right for
Multiple Myeloma
Vanderbilt-Ingram Cancer Center 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT03384914
What this trial is testing

Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer

Who this might be right for
Breast Cancer FemaleBreast Cancer, MaleBreast Cancer Stage I+5 more
H. Lee Moffitt Cancer Center and Research Institute 119
Load More Results